Medical Countermeasures Needle-Free Influenza Vaccines: HKUMed Advances New Live-Attenuated Platforms with Cross-Subtype PotentialGlobal Biodefense StaffMay 9, 2025
Medical Countermeasures Repositioning Smallpox Vaccines for a New Threat: MpoxGlobal Biodefense StaffMay 8, 2025
Medical Countermeasures New Monoclonal Antibodies Offer Hope for Universal Influenza TreatmentGlobal Biodefense StaffMay 1, 2025
Top Pharma and Research Institutes Partner for ‘TB Drug Accelerator’ Medical Countermeasures June 27, 2012 …
Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers Contracts + Grants June 19, 2012 …